{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T22:37:02Z","timestamp":1790462222750,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T00:00:00Z","timestamp":1616457600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T00:00:00Z","timestamp":1616457600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>To compare plasma fatty acids (FAs) between participants with primary open-angle glaucoma (POAG) and participants without neuropathy in an elderly population and to investigate specific FAs pattern in POAG.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a population-based study in participants older than 75\u2009years. Participants underwent a comprehensive eye examination with optic nerve photographs, visual field test and optic nerve OCT with RNFL thickness measurement. Glaucomatous status was defined according to the International Society for Epidemiologic and Geographical Ophthalmology classification. Lipids were extracted from plasma and FAs methylesters prepared and analyzed by gas chromatography-mass spectrometry.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among the 1153 participants of the Montrachet study 810 were retained for analysis and 68 had POAG. The mean age was 82.11\u2009\u00b1\u20093.67. In multivariable analysis FAs levels were not different between POAG participants and controls (\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u20090.078). A FAs pattern characterized by high negative weight of gamma-linoleic acid, eicosapentaenoic acid polyunsaturated FAs (PUFAs), Cis-7 hexadecenoic acid monounsaturated FAs (MUFAs) and high positive weight of eicosadienoic acid, docosatetraenoic acid, docosapentaenoic n-6, alpha linoleic acid PUFAs, eicosenoic acid MUFAs, margaric acid and behenic acid saturated FAs was positively associated with POAG. After adjustment for major confounders, individuals in the upper tertile of FAs pattern scores compared with those in the lower tertile were more likely to present POAG (OR\u2009=\u20093.09 [95% CI 1.29\u20137.40]\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u20090.013).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We found no significant difference regarding isolated plasma FAs between participants with POAG and participants without neuropathy in elderly but specific FAs pattern might be associated with POAG.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12886-021-01910-w","type":"journal-article","created":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T06:03:30Z","timestamp":1616479410000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Plasma fatty acids and primary open-angle glaucoma in the elderly: the Montrachet population-based study"],"prefix":"10.1186","volume":"21","author":[{"given":"Alicia","family":"Chemaly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Arnould","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alassane","family":"Seydou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Henry","family":"Gabrielle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Baudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niyazi","family":"Acar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Creuzot-Garcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,23]]},"reference":[{"issue":"12","key":"1910_CR1","doi-asserted-by":"publisher","first-page":"e1221","DOI":"10.1016\/S2214-109X(17)30393-5","volume":"5","author":"SR Flaxman","year":"2017","unstructured":"Flaxman SR, Bourne RRA, Resnikoff S, Ackland P, Braithwaite T, Cicinelli MV, et al. Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis. Lancet Glob Health. 2017;5(12):e1221\u201334. https:\/\/doi.org\/10.1016\/S2214-109X(17)30393-5.","journal-title":"Lancet Glob Health"},{"issue":"11","key":"1910_CR2","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","volume":"121","author":"Y-C Tham","year":"2014","unstructured":"Tham Y-C, Li X, Wong TY, Quigley HA, Aung T, Cheng C-Y. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmol. 2014;121(11):2081\u201390. https:\/\/doi.org\/10.1016\/j.ophtha.2014.05.013.","journal-title":"Ophthalmol"},{"key":"1910_CR3","doi-asserted-by":"crossref","unstructured":"The advanced glaucoma intervention study, 6: effect of cataract on visual field and visual acuity. The AGIS investigators. Arch Ophthalmol. 2000;118:1639\u201352.","DOI":"10.1001\/archopht.118.12.1639"},{"issue":"10108","key":"1910_CR4","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1016\/S0140-6736(17)31469-1","volume":"390","author":"JB Jonas","year":"2017","unstructured":"Jonas JB, Aung T, Bourne RR, Bron AM, Ritch R, Panda-Jonas S. Glaucoma. Lancet. 2017;390(10108):2183\u201393. https:\/\/doi.org\/10.1016\/S0140-6736(17)31469-1.","journal-title":"Lancet"},{"issue":"8","key":"1910_CR5","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1001\/archopht.1991.01080080050026","volume":"109","author":"A Sommer","year":"1991","unstructured":"Sommer A, Tielsch JM, Katz J, Quigley HA, Gottsch JD, Javitt J, et al. Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. The Baltimore eye survey. Arch Ophthalmol. 1991;109(8):1090\u20135. https:\/\/doi.org\/10.1001\/archopht.1991.01080080050026.","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"1910_CR6","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/S1350-9462(02)00008-3","volume":"21","author":"J Flammer","year":"2002","unstructured":"Flammer J, Orgul S, Costa VP, et al. The impact of ocular blood flow in glaucoma. Prog Retin Eye Res. 2002;21(4):359\u201393. https:\/\/doi.org\/10.1016\/S1350-9462(02)00008-3.","journal-title":"Prog Retin Eye Res"},{"issue":"3","key":"1910_CR7","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S1350-9462(00)00028-8","volume":"20","author":"J Flammer","year":"2001","unstructured":"Flammer J, Pache M, Resink T. Vasospasm, its role in the pathogenesis of diseases with particular reference to the eye. Prog Retin Eye Res. 2001;20(3):319\u201349. https:\/\/doi.org\/10.1016\/S1350-9462(00)00028-8.","journal-title":"Prog Retin Eye Res"},{"issue":"11","key":"1910_CR8","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1016\/S0161-6420(01)00873-9","volume":"108","author":"PR Lichter","year":"2001","unstructured":"Lichter PR, Musch DC, Gillespie BW, Guire KE, Janz NK, Wren PA, et al. Interim clinical outcomes in the collaborative initial glaucoma treatment study comparing initial treatment randomized to medications or surgery. Ophthalmology. 2001;108(11):1943\u201353. https:\/\/doi.org\/10.1016\/S0161-6420(01)00873-9.","journal-title":"Ophthalmology"},{"issue":"10","key":"1910_CR9","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1001\/archopht.120.10.1268","volume":"120","author":"A Heijl","year":"2002","unstructured":"Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M. Reduction of intraocular pressure and glaucoma progression: results from the early manifest glaucoma trial. Arch Ophthalmol. 2002;120(10):1268\u201379. https:\/\/doi.org\/10.1001\/archopht.120.10.1268.","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"1910_CR10","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.preteyeres.2006.07.003","volume":"25","author":"G Tezel","year":"2006","unstructured":"Tezel G. Oxidative stress in glaucomatous neurodegeneration: mechanisms and consequences. Prog Retin Eye Res. 2006;25(5):490\u2013513. https:\/\/doi.org\/10.1016\/j.preteyeres.2006.07.003.","journal-title":"Prog Retin Eye Res"},{"issue":"4","key":"1910_CR11","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.survophthal.2012.08.010","volume":"58","author":"R Vohra","year":"2013","unstructured":"Vohra R, Tsai JC, Kolko M. The role of inflammation in the pathogenesis of glaucoma. Surv Ophthalmol. 2013;58(4):311\u201320. https:\/\/doi.org\/10.1016\/j.survophthal.2012.08.010.","journal-title":"Surv Ophthalmol"},{"issue":"4","key":"1910_CR12","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1080\/07315724.2004.10719371","volume":"23","author":"P Benatti","year":"2004","unstructured":"Benatti P, Peluso G, Nicolai R, Calvani M. Polyunsaturated fatty acids: biochemical, nutritional and epigenetic properties. J Am Coll Nutr. 2004;23(4):281\u2013302. https:\/\/doi.org\/10.1080\/07315724.2004.10719371.","journal-title":"J Am Coll Nutr"},{"key":"1910_CR13","doi-asserted-by":"publisher","unstructured":"Kao Y-C, Ho P-C, Tu Y-K, Jou I-M, Tsai K-J. Lipids and Alzheimer's disease. Int J Mol Sci. 2020;21(4). https:\/\/doi.org\/10.3390\/ijms21041505.","DOI":"10.3390\/ijms21041505"},{"issue":"6","key":"1910_CR14","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.neurobiolaging.2006.04.006","volume":"28","author":"AM Lynch","year":"2007","unstructured":"Lynch AM, Loane DJ, Minogue AM, Clarke RM, Kilroy D, Nally RE, et al. Eicosapentaenoic acid confers neuroprotection in the amyloid-beta challenged aged hippocampus. Neurobiol Aging. 2007;28(6):845\u201355. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2006.04.006.","journal-title":"Neurobiol Aging"},{"issue":"2","key":"1910_CR15","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/00075197-200403000-00005","volume":"7","author":"C von Schacky","year":"2004","unstructured":"von Schacky C. Omega-3 fatty acids and cardiovascular disease. Curr Opin Clin Nutr Metab Care. 2004;7(2):131\u20136. https:\/\/doi.org\/10.1097\/00075197-200403000-00005.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"5","key":"1910_CR16","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1111\/j.1471-4159.2006.04061.x","volume":"98","author":"OL German","year":"2006","unstructured":"German OL, Insua MF, Gentili C, Rotstein NP, Politi LE. Docosahexaenoic acid prevents apoptosis of retina photoreceptors by activating the ERK\/MAPK pathway. J Neurochem. 2006;98(5):1507\u201320. https:\/\/doi.org\/10.1111\/j.1471-4159.2006.04061.x.","journal-title":"J Neurochem"},{"issue":"1","key":"1910_CR17","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.preteyeres.2004.06.002","volume":"24","author":"JP SanGiovanni","year":"2005","unstructured":"SanGiovanni JP, Chew EY. The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Prog Retin Eye Res. 2005;24(1):87\u2013138. https:\/\/doi.org\/10.1016\/j.preteyeres.2004.06.002.","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"1910_CR18","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12944-019-1049-9","volume":"18","author":"AR Eynard","year":"2019","unstructured":"Eynard AR, Repossi G. Role of \u03c93 polyunsaturated fatty acids in diabetic retinopathy: a morphological and metabolically cross talk among blood retina barriers damage, autoimmunity and chronic inflammation. Lipids Health Dis. 2019;18(1):114. https:\/\/doi.org\/10.1186\/s12944-019-1049-9.","journal-title":"Lipids Health Dis"},{"issue":"6","key":"1910_CR19","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.exer.2009.07.008","volume":"89","author":"N Acar","year":"2009","unstructured":"Acar N, Berdeaux O, Juaneda P, Gr\u00e9goire S, Cabaret S, Joffre C, et al. Red blood cell plasmalogens and docosahexaenoic acid are independently reduced in primary open-angle glaucoma. Exp Eye Res. 2009;89(6):840\u201353. https:\/\/doi.org\/10.1016\/j.exer.2009.07.008.","journal-title":"Exp Eye Res"},{"issue":"3","key":"1910_CR20","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.plefa.2005.11.007","volume":"74","author":"H Ren","year":"2006","unstructured":"Ren H, Magulike N, Ghebremeskel K, Crawford M. Primary open-angle glaucoma patients have reduced levels of blood docosahexaenoic and eicosapentaenoic acids. Prostaglandins Leukot Essent Fatty Acids. 2006;74(3):157\u201363. https:\/\/doi.org\/10.1016\/j.plefa.2005.11.007.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"3","key":"1910_CR21","doi-asserted-by":"publisher","first-page":"476","DOI":"10.3980\/j.issn.2222-3959.2015.03.08","volume":"8","author":"M Yu","year":"2015","unstructured":"Yu M, Chen B, Gong B, Shuai P, Wu Z-Z, Lin W. Association of n3 and n6 polyunsaturated fatty acids in red blood cell membrane and plasma with severity of normal tension glaucoma. Int J Ophthalmol. 2015;8(3):476\u201383. https:\/\/doi.org\/10.3980\/j.issn.2222-3959.2015.03.08.","journal-title":"Int J Ophthalmol"},{"issue":"2","key":"1910_CR22","doi-asserted-by":"publisher","first-page":"e90","DOI":"10.1111\/aos.12842","volume":"94","author":"C Creuzot-Garcher","year":"2016","unstructured":"Creuzot-Garcher C, Binquet C, Daniel S, Bretillon L, Acar N, de Lazzer A, et al. The Montrachet study: study design, methodology and analysis of visual acuity and refractive errors in an elderly population. Acta Ophthalmol. 2016;94(2):e90\u20137. https:\/\/doi.org\/10.1111\/aos.12842.","journal-title":"Acta Ophthalmol"},{"key":"1910_CR23","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1159\/000072920","volume":"22","author":"Group CS","year":"2003","unstructured":"Group CS. Vascular factors and risk of dementia: design of the Three-City study and baseline characteristics of the study population. Neuroepidemiology. 2003;22:316\u201325.","journal-title":"Neuroepidemiology"},{"issue":"4","key":"1910_CR24","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","volume":"61","author":"E von Elm","year":"2008","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344\u20139. https:\/\/doi.org\/10.1016\/j.jclinepi.2007.11.008.","journal-title":"J Clin Epidemiol"},{"issue":"jul08 1","key":"1910_CR25","doi-asserted-by":"publisher","first-page":"a718","DOI":"10.1136\/bmj.a718","volume":"337","author":"T Groves","year":"2008","unstructured":"Groves T. Enhancing the quality and transparency of health research. BMJ. 2008;337(jul08 1):a718. https:\/\/doi.org\/10.1136\/bmj.a718.","journal-title":"BMJ"},{"issue":"2","key":"1910_CR26","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1136\/bjo.86.2.238","volume":"86","author":"PJ Foster","year":"2002","unstructured":"Foster PJ, Buhrmann R, Quigley HA, Johnson GJ. The definition and classification of glaucoma in prevalence surveys. Br J Ophthalmol. 2002;86(2):238\u201342. https:\/\/doi.org\/10.1136\/bjo.86.2.238.","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"1910_CR27","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1167\/iovs.18-26510","volume":"60","author":"J Blanc","year":"2019","unstructured":"Blanc J, Seydou A, Ben Ghezala I, Deschasse C, Meillon C, Bron AM, et al. Vitreomacular Interface abnormalities and glaucoma in an elderly population (the MONTRACHET study). Invest Ophthalmol Vis Sci. 2019;60(6):1996\u20132002. https:\/\/doi.org\/10.1167\/iovs.18-26510.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1910_CR28","volume-title":"Clinical decisions in glaucoma","author":"E Hodapp","year":"1993","unstructured":"Hodapp E, Parrish R, Anderson DR. Clinical decisions in glaucoma; 1993."},{"issue":"6","key":"1910_CR29","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1001\/archopht.1992.01080180084033","volume":"110","author":"P Asman","year":"1992","unstructured":"Asman P, Heijl A. Glaucoma Hemifield test. Automated visual field evaluation. Arch Ophthalmol. 1992;110(6):812\u20139. https:\/\/doi.org\/10.1001\/archopht.1992.01080180084033.","journal-title":"Arch Ophthalmol"},{"issue":"10","key":"1910_CR30","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1097\/IJG.0000000000001342","volume":"28","author":"H \u00d6hnell","year":"2019","unstructured":"\u00d6hnell H, Bengtsson B, Heijl A. Making a correct diagnosis of glaucoma: data from the EMGT. J Glaucoma. 2019;28(10):859\u201364. https:\/\/doi.org\/10.1097\/IJG.0000000000001342.","journal-title":"J Glaucoma"},{"issue":"1","key":"1910_CR31","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/0009-8981(81)90235-7","volume":"114","author":"T Moilanen","year":"1981","unstructured":"Moilanen T, Nikkari T. The effect of storage on the fatty acid composition of human serum. Clin Chim Acta. 1981;114(1):111\u20136. https:\/\/doi.org\/10.1016\/0009-8981(81)90235-7.","journal-title":"Clin Chim Acta"},{"issue":"4","key":"1910_CR32","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/S0022-2275(20)40190-7","volume":"5","author":"WR Morrison","year":"1964","unstructured":"Morrison WR, Smith LM. Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride-methanol. J Lipid Res. 1964;5(4):600\u20138. https:\/\/doi.org\/10.1016\/S0022-2275(20)40190-7.","journal-title":"J Lipid Res"},{"key":"1910_CR33","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2147\/opth.s9418","volume":"4","author":"K Yuki","year":"2010","unstructured":"Yuki K, Kimura I, Tsubota K. Serum free fatty acids levels not associated with normal tension glaucoma. Clin Ophthalmol. 2010;4:91\u20134. https:\/\/doi.org\/10.2147\/opth.s9418.","journal-title":"Clin Ophthalmol"},{"key":"1910_CR34","unstructured":"Agence nationale de s\u00e9curit\u00e9 sanitaire de l\u2019alimentation, de l\u2019environnement et du travail. Acide gras de la famille des Om\u00e9ga 3 et syst\u00e8me cardiovasculaire : int\u00e9r\u00eat nutritionnel et all\u00e9gations. Available on: https:\/\/www.anses.fr\/fr\/content\/acide-gras-de-la-famille-des-om%C3%A9ga-3-et-syst%C3%A8me-cardiovasculaire%C2%A0-int%C3%A9r%C3%AAt-nutritionnel-et-0. Accessed (9 Aug 2020), 2003."},{"issue":"4","key":"1910_CR35","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/S0939-4753(04)80002-4","volume":"14","author":"O Eschen","year":"2004","unstructured":"Eschen O, Christensen JH, De Caterina R, Schmidt EB. Soluble adhesion molecules in healthy subjects: a dose-response study using n-3 fatty acids. Nutr Metab Cardiovasc Dis. 2004;14(4):180\u20135. https:\/\/doi.org\/10.1016\/S0939-4753(04)80002-4.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"3","key":"1910_CR36","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3109\/00365518609083667","volume":"46","author":"C Popp-Snijders","year":"1986","unstructured":"Popp-Snijders C, Schouten JA, van der Meer J, van der Veen EA. Fatty fish-induced changes in membrane lipid composition and viscosity of human erythrocyte suspensions. Scand J Clin Lab Invest. 1986;46(3):253\u20138. https:\/\/doi.org\/10.3109\/00365518609083667.","journal-title":"Scand J Clin Lab Invest"},{"key":"1910_CR37","doi-asserted-by":"publisher","first-page":"S87","DOI":"10.1016\/0039-6257(94)90051-5","volume":"38 Suppl","author":"P Hamard","year":"1994","unstructured":"Hamard P, Hamard H, Dufaux J. Blood flow rate in the microvasculature of the optic nerve head in primary open angle glaucoma. A new approach. Surv Ophthalmol. 1994;38 Suppl:S87\u201393 discussion S94.","journal-title":"Surv Ophthalmol"},{"issue":"8","key":"1910_CR38","doi-asserted-by":"publisher","first-page":"3586","DOI":"10.1167\/iovs.08-1735","volume":"49","author":"CTO Nguyen","year":"2008","unstructured":"Nguyen CTO, Vingrys AJ, Bui BV. Dietary omega-3 fatty acids and ganglion cell function. Invest Ophthalmol Vis Sci. 2008;49(8):3586\u201394. https:\/\/doi.org\/10.1167\/iovs.08-1735.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"1910_CR39","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1167\/iovs.06-0585","volume":"48","author":"CTO Nguyen","year":"2007","unstructured":"Nguyen CTO, Bui BV, Sinclair AJ, Vingrys AJ. Dietary omega 3 fatty acids decrease intraocular pressure with age by increasing aqueous outflow. Invest Ophthalmol Vis Sci. 2007;48(2):756\u201362. https:\/\/doi.org\/10.1167\/iovs.06-0585.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"1910_CR40","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/IJG.0b013e318237cac7","volume":"22","author":"CTO Nguyen","year":"2013","unstructured":"Nguyen CTO, Vingrys AJ, Bui BV. Dietary \u03c9-3 deficiency and IOP insult are additive risk factors for ganglion cell dysfunction. J Glaucoma. 2013;22(4):269\u201377. https:\/\/doi.org\/10.1097\/IJG.0b013e318237cac7.","journal-title":"J Glaucoma"},{"issue":"6","key":"1910_CR41","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/j.1755-3768.2011.02356.x","volume":"91","author":"J-P Renard","year":"2013","unstructured":"Renard J-P, Rouland J-F, Bron A, Sellem E, Nordmann JP, Baudouin C, et al. Nutritional, lifestyle and environmental factors in ocular hypertension and primary open-angle glaucoma: an exploratory case-control study. Acta Ophthalmol. 2013;91(6):505\u201313. https:\/\/doi.org\/10.1111\/j.1755-3768.2011.02356.x.","journal-title":"Acta Ophthalmol"},{"issue":"2","key":"1910_CR42","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1001\/jamaophthalmol.2017.5702","volume":"136","author":"YE Wang","year":"2018","unstructured":"Wang YE, Tseng VL, Yu F, Caprioli J, Coleman AL. Association of Dietary Fatty Acid Intake with glaucoma in the United States. JAMA Ophthalmol. 2018;136(2):141\u20137. https:\/\/doi.org\/10.1001\/jamaophthalmol.2017.5702.","journal-title":"JAMA Ophthalmol"},{"issue":"5","key":"1910_CR43","doi-asserted-by":"publisher","first-page":"637","DOI":"10.5301\/EJO.2010.6212","volume":"21","author":"JJ Garcia-Medina","year":"2011","unstructured":"Garcia-Medina JJ, Pinazo-Duran MD, Garcia-Medina M, Zanon-Moreno V, Pons-Vazquez S. A 5-year follow-up of antioxidant supplementation in type 2 diabetic retinopathy. Eur J Ophthalmol. 2011;21(5):637\u201343. https:\/\/doi.org\/10.5301\/EJO.2010.6212.","journal-title":"Eur J Ophthalmol"},{"issue":"5","key":"1910_CR44","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/ajcn\/79.5.755","volume":"79","author":"JH Kang","year":"2004","unstructured":"Kang JH, Pasquale LR, Willett WC, Rosner BA, Egan KM, Faberowski N, et al. Dietary fat consumption and primary open-angle glaucoma. Am J Clin Nutr. 2004;79(5):755\u201364. https:\/\/doi.org\/10.1093\/ajcn\/79.5.755.","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"1910_CR45","doi-asserted-by":"publisher","first-page":"925S","DOI":"10.1093\/jn\/133.3.925S","volume":"133","author":"L Arab","year":"2003","unstructured":"Arab L. Biomarkers of fat and fatty acid intake. J Nutr. 2003;133(3):925S\u201332S. https:\/\/doi.org\/10.1093\/jn\/133.3.925S.","journal-title":"J Nutr"},{"issue":"4","key":"1910_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0035102","volume":"7","author":"N Acar","year":"2012","unstructured":"Acar N, Berdeaux O, Gr\u00e9goire S, Cabaret S, Martine L, Gain P, et al. Lipid composition of the human eye: are red blood cells a good mirror of retinal and optic nerve fatty acids? PLoS One. 2012;7(4):e35102. https:\/\/doi.org\/10.1371\/journal.pone.0035102.","journal-title":"PLoS One"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-021-01910-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12886-021-01910-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-021-01910-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T06:04:11Z","timestamp":1616479451000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-021-01910-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,23]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1910"],"URL":"https:\/\/doi.org\/10.1186\/s12886-021-01910-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-244629\/v1","asserted-by":"object"}]},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,23]]},"assertion":[{"value":"16 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study has been approved by the Ethical Committee of the 3 Cities Study and registered as 2009-A00448\u201349. Written informed consent was obtained from the participants or from legal guardians of the participants if they are blind and the study followed the tenets of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no non-financial competing interests.Disclosure: AC, None; LA, None; AS, None; PHG, None; FB, Novartis (C), Thea (C); NA, None; CCG, Allergan (C), Bayer (C), Horus (C), Novartis (C), Roche (C), Th\u00e9a (C).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"146"}}